Seven immunocompetent patients aged > 50 years old presented with herpes zoster (HZ) infection in a median of 9 days (range 7–20) after vaccination against SARS-CoV-2. The occurrence of HZ within the time window 1–21 days after vaccination defined for increased risk and the reported T cell-mediated immunity involvement suggest that COVID-19 vaccination is a probable cause of HZ. These cases support the importance of continuing assessment of vaccine safety during the ongoing massive vaccination for the COVID-19 pandemic and encourage reporting and communication of any vaccination-associated adverse event.
All Keywords
【저자키워드】 SARS-CoV-2, mRNA vaccines, herpes zoster, 【초록키워드】 Vaccine, vaccination, COVID-19 pandemic, Infection, COVID-19 vaccination, adverse event, Patient, Cell-mediated immunity, Support, increased risk, Occurrence, defined, reported, median, 【제목키워드】 Reactivation, Zoster,
【저자키워드】 SARS-CoV-2, mRNA vaccines, herpes zoster, 【초록키워드】 Vaccine, vaccination, COVID-19 pandemic, Infection, COVID-19 vaccination, adverse event, Patient, Cell-mediated immunity, Support, increased risk, Occurrence, defined, reported, median, 【제목키워드】 Reactivation, Zoster,